DHCR24 and neoplasm: DHCR24 promotes tumor proliferation, apoptosis resistance, and invasion through cholesterol biosynthesis [29], and activates the PI3K‐AKT signaling pathway [30, 31], while RAG1, reexpressed by tumor‐infiltrating T cells—may facilitate immune evasion via TCR specificity remodeling [32].